← All patents

US9611266B2

Compounds and anti-tumor NQO1 substrates

University of Texas System

Abstract

Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Paul J. Hergenrother
Priority date
October 14, 2011
Filing date
January 11, 2016
Grant date
April 04, 2017
Publication date
April 04, 2017
Language
en
Metadata fetched
August 29, 2026 00:24